CL2007003723A1 - SUBSTITUTED CYCLICAL OR HETEROCICLIC COMPOUNDS, NON-STEROID MODULATORS OF THE PROGESTERONE RECEIVER; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT AND / OR PREVENT GYNECOLOGICAL DISEASES SUCH AS ENDOMETRIOSIS AND DISMENORREA, DEPENDENT TUMORS - Google Patents

SUBSTITUTED CYCLICAL OR HETEROCICLIC COMPOUNDS, NON-STEROID MODULATORS OF THE PROGESTERONE RECEIVER; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT AND / OR PREVENT GYNECOLOGICAL DISEASES SUCH AS ENDOMETRIOSIS AND DISMENORREA, DEPENDENT TUMORS

Info

Publication number: CL2007003723A1
Authority: CL; Chile
Prior art keywords: dismenorrea; endometriosis; cyclical; treat; substituted
Prior art date: 2006-12-21

Application number

CL2007003723A

Other languages

Spanish (es)

Inventor

Schwede Thomas Andrew Wolfgang

Original Assignee

Bayer Schering Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-21

Filing date

2007-12-20

Publication date

2008-08-08

2007-05-21 Priority claimed from DE102007023614A external-priority patent/DE102007023614A1/en

2007-12-20 Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag

2008-08-08 Publication of CL2007003723A1 publication Critical patent/CL2007003723A1/en

Links

RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 title 2
201000009273 Endometriosis Diseases 0.000 title 1
206010028980 Neoplasm Diseases 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
230000001419 dependent effect Effects 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
229960003387 progesterone Drugs 0.000 title 1
239000000186 progesterone Substances 0.000 title 1

CL2007003723A 2006-12-21 2007-12-20 SUBSTITUTED CYCLICAL OR HETEROCICLIC COMPOUNDS, NON-STEROID MODULATORS OF THE PROGESTERONE RECEIVER; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT AND / OR PREVENT GYNECOLOGICAL DISEASES SUCH AS ENDOMETRIOSIS AND DISMENORREA, DEPENDENT TUMORS CL2007003723A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102006061912		2006-12-21
DE102007023614A DE102007023614A1 (en)	2007-05-21	2007-05-21	New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula

Publications (1)

Publication Number	Publication Date
CL2007003723A1 true CL2007003723A1 (en)	2008-08-08

Family

ID=40261603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2007003723A CL2007003723A1 (en)	2006-12-21	2007-12-20	SUBSTITUTED CYCLICAL OR HETEROCICLIC COMPOUNDS, NON-STEROID MODULATORS OF THE PROGESTERONE RECEIVER; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT AND / OR PREVENT GYNECOLOGICAL DISEASES SUCH AS ENDOMETRIOSIS AND DISMENORREA, DEPENDENT TUMORS

Country Status (1)

Country	Link
CL (1)	CL2007003723A1 (en)

2007
- 2007-12-20 CL CL2007003723A patent/CL2007003723A1/en unknown

Similar Documents

Publication	Publication Date	Title
CL2007002199A1 (en)	2008-03-07	COMPOUNDS DERIVED FROM SULFONIL AMIDA, RECEIVER MODULATORS CB2; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT INFLAMMATORY AND AUTOINMUNE DISEASES.
CL2008000690A1 (en)	2008-09-12	COMPOUNDS DERIVED FROM INDOL-3-PROPIONIC ACID; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS HYPERLIPIDEMIA, HYPERTENSION; AMONG OTHER.
BRPI0917017B8 (en)	2021-05-25	s-nitrosoglutathione reductase pyrrole inhibitors as therapeutic agents
CL2007003226A1 (en)	2008-02-08	COMPOUNDS DERIVED FROM PIRIDINONA; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT CANCER.
CL2007002377A1 (en)	2008-04-04	COMPOUNDS DERIVED FROM QUINAZOLINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE AS ANTICANCERIGENO.
BRPI0915084B8 (en)	2021-05-25	compound, and, pharmaceutical composition
CL2007003774A1 (en)	2008-04-18	COMPOUNDS DERIVED FROM QUINAZOLINA SUBSTITUTES, INHIBITORS OF QUINASA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER, ATEROSCLEROSIS AND ARTHRITIS.
CL2007003629A1 (en)	2008-08-08	ARIL-SUBSTITUTED HETEROCICLIC COMPOUNDS, TYPE I CANNABINOID RECEIVER MODULATORS (CB1); PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS METABOLIC DISORDERS AND COGNITIVE DISORDERS.
BR112012002331A2 (en)	2019-09-24	antiviral composition, pharmaceutical composition and use of effective amount of pharmaceutical composition
CL2008001304A1 (en)	2008-09-22	COMPOUNDS DERIVED FROM REPLACED INDOL, INHIBITORS OF THE 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP); PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS COPD, CARDIOVASCULAR DISEASE AND INFLAMMATION.
BRPI0719210A2 (en)	2015-05-05	Use of spiro-oxindole compounds as therapeutic agents
CL2007001869A1 (en)	2008-02-08	COMPOUNDS DERIVED FROM BENCIMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITIONS; AND USE FOR THE TREATMENT AND / OR PROFILAXIS OF DISEASES MODULATED WITH FXR AGONISTS, SUCH AS DISLIPIDEMIAS, DIABETES, CANCER, OSTEOPOROSIS AND E
CL2009000349A1 (en)	2010-02-19	Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
CL2007003832A1 (en)	2008-07-25	COMPOUNDS DERIVED FROM AZAESPIRO; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE TO PREVENT AND TREAT ANXIETY, DEPRESSIVE DISORDERS, AMONG OTHER DISEASES.
CL2013003816A1 (en)	2014-06-20	Compounds derived from carboxamide and urea comprising aromatic substituted pyrazole, vanilloid receptor binders; pharmaceutical composition that includes them; and its use in the treatment and / or prophylaxis of pain, migraine, parkinson's disease, gastrointestinal disorders, osteoporosis, among other diseases.
CL2007003266A1 (en)	2008-07-04	COMPOUNDS DERIVED FROM PROGESTERONA, ANTAGONISTS OF THE PROGESTERONE RECEIVER; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF ENDOMETRIOSIS, MYOMAS OR TUMORS DEPENDENT ON HORMONES.
CL2015002606A1 (en)	2016-03-04	Compound.
CL2007001022A1 (en)	2008-02-08	COMPOUNDS DERIVED FROM 1H-INDOL-2-CARBOXAMIDE; PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT AND / OR PREVENTION OF DISEASES ASSOCIATED WITH THE MODULATION OF H3 RECEPTORS AS OBESITY, TYPE II DIABETES AND
EA201101116A1 (en)	2012-03-30	PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
BRPI0914410A2 (en)	2016-08-16	injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases.
CO6420342A2 (en)	2012-04-16	PIRAZOL DERIVATIVES USED AS AN RECRUITOR OF THE CCR4 RECEIVER
EA201101118A1 (en)	2012-03-30	PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
CU20120175A7 (en)	2013-05-31	COMPOUNDS DERIVED FROM 6,7-DIHIDRO-5H-BENZO [7] ANNULARS
CL2008000641A1 (en)	2008-09-12	COMPOUNDS DERIVED FROM SUBSTITUTED AMIDAS; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF INSOMNIUM, SEXUAL DYSFUNCTION, SCHIZOPHRENIA, BETWEEN OTHER SICK
CL2007003194A1 (en)	2008-06-13	CRYSTAL FORMS OF THE HEMI ALISQUIRENE FUMARATE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH CRYSTAL FORMS; AND ITS USE TO TREAT DISEASES THAT ARE MODULATED WITH AT1 RECEIVER BLOCK, SUCH AS REGULATION